NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ABT

Abbott Laboratories

Apr 21 • 04:00PM ET

129.89

Dollar change -1.09
Percentage change -0.83	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ MDT DHR BAX SYK ISRG TDOC BDX RMD ZBH

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IHI VHT

Scroll to Statements

Index	S&P 500	P/E	16.82	EPS (ttm)	7.72	Insider Own	0.67%	Shs Outstand	1.73B	Perf Week	2.37%
Market Cap	225.27B	Forward P/E	22.87	EPS next Y	5.68	Insider Trans	-6.10%	Shs Float	1.72B	Perf Month	2.45%
Income	13.46B	PEG	1.63	EPS next Q	1.25	Inst Own	78.92%	Short Float	1.27%	Perf Quarter	14.46%
Sales	42.34B	P/S	5.32	EPS this Y	10.45%	Inst Trans	2.75%	Short Ratio	2.85	Perf Half Y	10.24%
Book/sh	27.52	P/B	4.72	EPS next Y	10.13%	ROA	17.27%	Short Interest	21.79M	Perf Year	22.65%
Cash/sh	4.59	P/C	28.28	EPS next 5Y	10.34%	ROE	30.96%	52W Range	99.71 - 141.23	Perf YTD	14.84%
Dividend Est.	2.37 (1.83%)	P/FCF	35.47	EPS past 5Y	29.98%	ROI	21.99%	52W High	-8.03%	Beta	0.72
Dividend TTM	2.28 (1.76%)	Quick Ratio	1.23	Sales past 5Y	6.15%	Gross Margin	58.23%	52W Low	30.27%	ATR (14)	3.87
Dividend Ex-Date	Apr 15, 2025	Current Ratio	1.67	EPS Y/Y TTM	134.50%	Oper. Margin	17.10%	RSI (14)	52.54	Volatility	2.53% 2.98%
Employees	114000	Debt/Eq	0.32	Sales Y/Y TTM	5.00%	Profit Margin	31.78%	Recom	1.83	Target Price	142.90
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	8.76%	Payout	29.33%	Rel Volume	0.79	Prev Close	130.98
Sales Surprise	-0.46%	EPS Surprise	1.66%	Sales Q/Q	3.95%	Earnings	Apr 16 BMO	Avg Volume	7.64M	Price	129.89
SMA20	1.24%	SMA50	-0.71%	SMA200	9.90%	Trades		Volume	6,044,348	Change	-0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110
Jul-06-22	Initiated	Wolfe Research	Underperform	$95
Mar-02-22	Resumed	BofA Securities	Buy	$140
Jan-27-22	Reiterated	UBS	Buy	$138 → $142
Jan-27-22	Reiterated	Raymond James	Outperform	$150 → $143

Show Previous Ratings

Apr-19-25 12:06PM	Jim Cramer Applauds Abbott Laboratories (ABT): A Tour de Force Quarter - Robert Ford Is Keeping the Miles White Legacy Alive (Insider Monkey)
09:54AM	Abbott Labs' Rally Is Well Deserved - Fade The Rally For Now (Seeking Alpha)
Apr-18-25 02:03PM	Stock Market Swoon Could Hit Some P&C Insurers Harder Than Others (Seeking Alpha)
Apr-17-25 02:00PM	Should You Buy Boston Scientific Stock Ahead of Q1 Earnings? (Zacks)
12:05PM	Nvidia, AMD see charges due to new China export rules: Morning Buzz (TipRanks)
11:50AM	Loading…
11:50AM	Abbott price target raised to $140 from $138 at Evercore ISI (TipRanks)
10:00AM	5 Dividend Aristocrats So Good You'll Never Want to Sell (Motley Fool)
09:41AM	Company News for Apr 17, 2025 (Zacks)
08:20AM	Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
07:37AM	Tariff-Resistant Abbott Laboratories on Track for New Highs (MarketBeat)
06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
03:10AM	Banks Outperformed For Q1 But Strike Cautious Tone For The Rest Of 2025 (Seeking Alpha)
03:01AM	Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ... (GuruFocus.com)
01:08AM	Q1 2025 Abbott Laboratories Earnings Call (Thomson Reuters StreetEvents)
Apr-16-25 04:56PM	Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs (GuruFocus.com)
04:45PM	Loading…
04:45PM	S&P 500 Gains and Losses Today: Chip Stocks Drop as Top Firms Cite Export Restriction Effects (Investopedia)
04:10PM	Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers (Yahoo Finance Video)
04:04PM	Abbott Makes A Bullish Move, Shrugging Off Covid Test Malaise (Investor's Business Daily)
03:57PM	Abbott Q1: Flexible Supply Chain And Strong Growth In Medical Devices (Seeking Alpha)
03:49PM	Is Abbott Laboratories (ABT) the Best Dividend Monarch to Invest in Now? (Insider Monkey)
03:01PM	Analyst Report: Abbott Laboratories (Morningstar Research)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
02:11PM	Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities (Investopedia)
01:07PM	Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market (Zacks)
12:20PM	Abbott Labs Bracing for Tariffs as Profits Rise (The Wall Street Journal)
12:18PM	Top Stock Movers Now: Nvidia, ASML, Abbot Laboratories and More (Investopedia)
12:12PM	United Airlines & Abbott Labs earnings, Ackman's Hertz stake (Yahoo Finance Video)
12:03PM	Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know (StockStory)
11:55AM	Wall Street Lunch: Retail Sales Defy Expectations Amid Consumer Confidence Distress (Seeking Alpha)
11:24AM	Abbott Laboratories (ABT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
11:19AM	Loading…
11:19AM	Abbott Labs Forecasts Tariff Impact of a Few Hundred Million Dollars (The Wall Street Journal)
10:54AM	Pre-Markets Open in The Red (Zacks)
10:53AM	Abbott Laboratories stock pops on earnings beat (Yahoo Finance Video)
10:28AM	Retail Sales, Q1 Earnings Show Signs of "Pull Forward" (Zacks)
10:17AM	Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations (Barrons.com)
09:44AM	Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty (Benzinga)
09:30AM	Compared to Estimates, Abbott (ABT) Q1 Earnings: A Look at Key Metrics (Zacks)
09:21AM	Nvidia, ASML, Abbott Labs: Stocks to watch today (Quartz)
08:59AM	Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat (Investor's Business Daily)
08:59AM	Abbott Bounds Off 50-Day Line, Shrugging Off Covid Test Malaise (Investor's Business Daily)
08:45AM	Abbott (ABT) Q1 Earnings Beat Estimates (Zacks)
08:43AM	Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it (Zacks)
08:23AM	Abbott Labs Profit Jumps on Gains in Nutrition, Medical Devices (The Wall Street Journal)
08:15AM	Abbott Laboratories Reaffirms FY25 Outlook - Update (RTT News)
07:43AM	Abbott Laboratories (NYSE:ABT) Posts Q1 Sales In Line With Estimates (StockStory)
07:38AM	Abbott: Q1 Earnings Snapshot (Associated Press Finance)
07:33AM	Abbott maintains profit forecast, invests $500 million in US amid tariffs (Reuters)
07:32AM	Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings (Zacks)
07:30AM	Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance (PR Newswire)
Apr-15-25 03:02PM	"Rotation Carnage": Jim Cramer Blames a Bad Rotation for Abbott Laboratories (ABT)'s Fall from Grace (Insider Monkey)
09:28AM	Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings (Zacks)
08:39AM	Badger Meter Gears Up to Report Q1 Earnings: What's in the Offing? (Zacks)
08:35AM	How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings (Benzinga)
08:00AM	Abbott Laboratories (ABT) Q1 Earnings: What To Expect (StockStory)
Apr-14-25 08:42PM	5 Top Stock Charts for This Week (Zacks)
03:00PM	Tap Into the Silver Economy Boom With These Aging Demographics Stocks (Zacks)
12:18PM	International Growth Drives GMED Stock Amid Fierce Competition (Zacks)
09:48AM	BAX Stock Declines Despite Latest Product Launch Boosting Patient Care (Zacks)
08:24AM	Bruker Stock May Benefit Following Its Investment in Ridom GmbH (Zacks)
06:20AM	Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? (Zacks)
Apr-13-25 09:37AM	Wall Street Week Ahead (Seeking Alpha)
06:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-12-25 11:00AM	Goldman Sachs, J&J, To Report Earnings As Investors Watch Out For Retail Sales Data (Seeking Alpha)
01:27AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 13 (Seeking Alpha)
Apr-11-25 10:01AM	Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? (Zacks)
09:15AM	Seeking Clues to Abbott (ABT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Apr-10-25 05:50PM	Abbott (ABT) Stock Moves -2%: What You Should Know (Zacks)
09:34AM	Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device (Investor's Business Daily)
08:52AM	Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus (Zacks)
07:25AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
07:16AM	Should You Continue to Hold NVST Stock in Your Portfolio? (Zacks)
06:15AM	Vulcan Value Partners Q1 2025 Letter (Seeking Alpha)
02:37AM	Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Apr-09-25 03:00PM	Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On (Zacks)
10:00AM	Abbott (ABT) Earnings Expected to Grow: Should You Buy? (Zacks)
09:52AM	Is it the Right Time to Retain Labcorp Stock in Your Portfolio? (Zacks)
09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:47AM	TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock? (Zacks)
06:33AM	ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts (Zacks)
Apr-08-25 12:04PM	ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps (Zacks)
09:46AM	Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up (Zacks)
06:20AM	Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? (Zacks)
06:13AM	The Zacks Analyst Blog Highlights Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare (Zacks)
Apr-07-25 02:24PM	Is Abbott Laboratories (ABT) the Most Profitable Dividend Stock to Buy Now? (Insider Monkey)
08:48AM	Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? (Zacks)
08:14AM	5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem (Zacks)
Apr-06-25 08:54AM	Abbott Laboratories (ABT): One of the Best Dividend Kings to Buy for Safe Dividend Growth (Insider Monkey)
Apr-05-25 03:40AM	President Trump's Tariffs Have Arrived. 3 Things to Do to Protect Your Portfolio. (Motley Fool)
Apr-04-25 12:42PM	The Dow Needs A Refresh. These New Members Could Make It Sing. (Barrons.com) -5.46%
09:30AM	Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
08:09AM	Reasons to Add ABT Stock to Your Portfolio Right Now (Zacks)
06:51AM	Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM (Zacks)
05:01AM	Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks (StockStory)
Apr-03-25 05:57PM	?RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) (Seeking Alpha)
05:50PM	Abbott (ABT) Stock Moves -0.23%: What You Should Know (Zacks)
02:22PM	Analyst Report: Abbott Laboratories (Morningstar Research)
01:25PM	Global Expansion in EPD and Innovations Support Abbott Stock (Zacks)
Apr-02-25 09:40AM	Has EUROFINS SCIENT (ERFSF) Outpaced Other Medical Stocks This Year? (Zacks)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Apr-01-25 08:27AM	ABT Stock to Gain From Early CE Mark Approval of Volt PFA System (Zacks)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 06 '25	Option Exercise	80.98	91,167	7,382,704	163,095	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 07 '25	Option Exercise	80.98	200	16,196	72,128	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 06 '25	Sale	133.82	91,167	12,199,968	71,928	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 07 '25	Sale	136.65	200	27,329	71,928	Mar 07 06:55 PM
Lisa D. Earnhardt	Officer	Mar 07 '25	Proposed Sale	136.65	200	27,329		Mar 07 06:28 PM
Lisa D. Earnhardt	Officer	Mar 06 '25	Proposed Sale	133.82	91,167	12,199,967		Mar 06 05:47 PM
Wainer Andrea F	RETIRED EVP	Mar 03 '25	Sale	138.17	949	131,123	74,381	Mar 04 08:05 PM
Shroff Eric	Senior Vice President	Mar 03 '25	Sale	138.17	562	77,652	31,970	Mar 04 08:00 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 03 '25	Sale	138.17	1,111	153,507	66,878	Mar 04 07:49 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 03 '25	Sale	138.17	791	109,292	95,583	Mar 04 07:44 PM
MCCOY JOHN A. JR.	VICE PRESIDENT AND CONTROLLER	Mar 03 '25	Sale	138.17	562	77,652	21,061	Mar 04 07:39 PM
Eric Shroff	Officer	Mar 03 '25	Proposed Sale	138.17	562	77,651		Mar 03 08:40 PM
Andrea F. Wainer	Retired Officer	Mar 03 '25	Proposed Sale	138.17	949	131,123		Mar 03 08:18 PM
Louis H. Morrone	Officer	Mar 03 '25	Proposed Sale	138.17	1,111	153,506		Mar 03 08:08 PM
Mary K. Moreland	Officer	Mar 03 '25	Proposed Sale	138.17	791	109,292		Mar 03 07:58 PM
John A. McCoy, Jr.	Officer	Mar 03 '25	Proposed Sale	138.17	562	77,651		Mar 03 07:52 PM
Ford Robert B	CHAIRMAN AND CEO	Feb 05 '25	Option Exercise	38.40	285,388	10,958,899	505,447	Feb 07 05:51 PM
Ford Robert B	CHAIRMAN AND CEO	Feb 05 '25	Sale	131.17	285,388	37,435,200	220,059	Feb 07 05:51 PM
Robert B. Ford	Officer	Feb 05 '25	Proposed Sale	131.17	285,388	37,435,238		Feb 05 06:52 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Option Exercise	38.40	131,360	5,044,224	316,166	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	58,428	2,243,635	243,234	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Sale	128.35	131,360	16,859,675	184,806	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.07	58,428	7,482,629	184,806	Jan 31 07:16 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	23,771	912,806	149,468	Jan 31 07:08 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.50	23,771	3,054,574	125,697	Jan 31 07:08 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Jan 28 '25	Sale	127.39	2,644	336,819	0	Jan 30 07:33 PM
Hubert L. Allen	Officer	Jan 30 '25	Proposed Sale	128.07	58,428	7,482,628		Jan 30 05:33 PM
Daniel Gesua Sive Salvadori	Officer	Jan 30 '25	Proposed Sale	128.50	23,771	3,054,573		Jan 30 05:26 PM
Hubert L. Allen	Officer	Jan 29 '25	Proposed Sale	128.35	131,360	16,859,675		Jan 29 05:30 PM
Funck, Jr. Robert E.	Officer	Nov 04 '24	Proposed Sale	120.00	15,000	1,800,000		Nov 04 04:02 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Option Exercise	47.00	157,421	7,398,787	342,227	Oct 23 05:10 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Sale	117.04	157,421	18,424,298	184,806	Oct 23 05:10 PM
ALLEN HUBERT L	Officer	Oct 21 '24	Proposed Sale	118.89	157,421	18,715,783		Oct 21 04:08 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Option Exercise	47.19	141,679	6,685,975	361,738	Sep 13 05:24 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Sale	116.41	141,679	16,493,218	220,059	Sep 13 05:24 PM
Robert B. Ford	Officer	Sep 12 '24	Proposed Sale	116.41	141,679	16,492,852		Sep 12 06:20 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Sep 04 '24	Sale	114.83	27	3,100	18,681	Sep 04 07:52 PM
Funck, Jr. Robert E.	Officer	Sep 04 '24	Proposed Sale	115.00	30,000	3,450,000		Sep 04 04:04 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Option Exercise	47.00	10,097	474,559	221,438	May 14 05:35 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Sale	104.57	10,097	1,055,819	211,341	May 14 05:35 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	May 07 '24	Sale	106.25	22,852	2,428,119	61,462	May 08 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your FINVIZ experience